The 17th #iwMyeloma24 meeting in Miami is over. Fantastic scientific discussions, friendship & new collaborations. Thank you to faculty & attendees for joining!

See you in Miami in 2025 for the 18th iwMyeloma meeting!

Gareth Morgan Multiple Myeloma RF International Myeloma Foundation HealthTree Foundation #mmsm

Patrick Blaney discussing non-random mutations in the non-coding genome in MM and the relative frequency of mutational signatures in these regions. Worth a ten minute watch back. VJHemOnc #mmsm

#iwMyeloma24 | Sarah Gooding from MRC MHU talks on brining genomics to the clinic 🧬🔍

#HemOnc #Myeloma #MMsm

#iwMyeloma24 ❘ Charlotte Pawlyn (Charlotte Pawlyn), of The ICR The Royal Marsden NHS Foundation Trust on lenalidomide resistance in #MultipleMyeloma

#HemOnc #Myeloma #MMsm #mmMRD

José Ángel Martínez-Climent (Cima Universidad de Navarra) discusses pre-clinical models of #MultipleMyeloma

#iwMyeloma24 #HemOnc #Myeloma #MMsm #ImmunoOnc

Here at #iwMyeloma24 , Dr. Felipe Prósper from Clínica Universidad de Navarra presents on epigenetic and microenvironment drivers of disease progression in #MultipleMyeloma

#HemOnc #Myeloma #MMsm #ImmunoOnc

George Mulligan (Multiple Myeloma RF) discusses MMRF clinical and translational research strategy

#iwMyeloma24 #HemOnc #Myeloma #MultipleMyeloma Multiple Myeloma RF

An engaging roundtable discussion at #iwMyeloma24 on updates from the Multiple Myeloma RF which included MyDRUG trial, CoMMpass, Immune Atlas and more...

#iwMyeloma24 #HemOnc #Myeloma #MMsm Multiple Myeloma RF

In the Clinical Trial Updates session at #iwMyeloma24 Suzanne Trudel (Princess Margaret Cancer Centre) discusses belantamab mafodotin for the treatment of #MultipleMyeloma

#Myeloma #MMsm #BelantamabMafodotin

Next up at #iwMyeloma 24 Thomas Martin discusses isatuximab combinations for the treatment of #MultipleMyeloma

#Myeloma #MMsm #iwMyeloma

#iwMyeloma 24 | Prof. Dr. Hermann Einsele discusses innovative CAR-T designs and targets in #MultipleMyeloma

#iwMyeloma #Myeloma #MMsm #CART

Next up, nizar jacques bahlis (@UCalgary) will discuss GPRC5D TCE resistance mechanisms and elranatamab at #iwMyeloma 24

#iwMyeloma #MultipleMyeloma #MMsm

In the final talk at #iwMyeloma 24 Ciara Freeman from Moffitt Cancer Center discusses the clinical management of #CART agents and their use in older adults

#iwMyeloma #MultipleMyeloma #MMsm

Amazing time participating and presenting at iwMyeloma 2024 with nizar jacques bahlis Benjamin G. Barwick and others!

Monobodies…… that is new to me! I need to learn more Faith E Davies #mmsm #iwMyeloma24 .

Last but not least Dr Freeman makes the case for Car T in the older age groups-it’s a wrap for iwMM 2024 great meeting thanks to everyone involved

Ciara Freeman speaking on clinical management of CAR-T therapy for older patients with multiple myeloma at the 17th International Workshop on Multiple #Myeloma in Miami, Day 2.

Paula Rodriguez-Otero speaking on developing bispecific antibodies for patients with multiple myeloma at the 17th International Workshop on Multiple #Myeloma in Miami, Day 2.

Next in the T-cell engagers session at #iwMyeloma 24 Hans Lee (MD Anderson Cancer Center) will present on ADs in the context of #MultipleMyeloma

#iwMyeloma #MMsm #Myeloma

Yi Lin speaking on developments in CAR-T therapy for patients with multiple myeloma at the 17th International Workshop on Multiple #Myeloma in Miami, Day 2.